Rosena Olubanke Oluwafemi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rosena Olubanke Oluwafemi has a total of 216 co-authors. Here are the top co-authors by number of shared publications:
- Adejumoke Idowu Ayede
Department of Paediatrics, College of Medicine, University of Ibadan and University College Hospital, Ibadan, Nigeria
2 shared publications Emmanuel O. Bello
Department of Paediatrics and Child Health, University of Medical Sciences, Ondo, Nigeria
2 shared publicationsMobolanle O. Oniya
Department of Biology, School of Life Sciences, Federal University of Technology, Akure, Ondo State, Nigeria
2 shared publicationsToluwani M. Oluwafemi
Department of Biology, School of Life Sciences, Federal University of Technology, Akure, Ondo State, Nigeria
2 shared publicationsAbbas Habibelahi
Neonatology, Neonatal Health Office, Ministry of Health and Medical Education, Tehran, Iran
1 shared publicationAbdul O. Momoh
Department of Biological Sciences, Faculty of Basic and Applied Science, Elizade University, Ilara-Mokin, Ondo State, Nigeria
1 shared publication
Latest Publications
- Open Access
- 4 August 2025
- Published by Wiley in Child: Care, Health and Development
- Vol. 51 (5) , e70152
Looped Audiovisual Health Education Talk Reduces Vaccine Clinic Wait Time in Nigeria
Background: Wait time at vaccine clinics is a barrier to routine childhood vaccinations in low‐ and middle‐income countries (LMICs). Waiting for a critical mass of clients to accrue before conducting the vaccine health education talk prolongs clinic time.Methods: We implemented a workflow change, including a looped audiovisual vaccine education talk on a solar‐powered television. We compared clients' average clinic time using a before‐and‐after study, time‐motion design, and surveyed providers and clients on their perspectives on the workflow change.Results: In the post‐implementation phase, compared to the pre‐implementation phase, the average clinic time for all clients and the subgroup who presented before 9:00 AM was significantly reduced by 13 and 31 min, respectively (p = 0.006 and < 0.000). Providers and clients were positive about the workflow change.Conclusion: A looped audiovisual vaccine education talk significantly reduces client vaccine clinic wait time and is acceptable to providers. Research on the impact of workflow change with alternate vaccine health talk delivery mode on vaccine uptake and completion is required.
- 4 August 2025
- Published by Wiley in Child: Care, Health and Development
- Vol. 51 (5) , e70152
Open AccessLooped Audiovisual Health Education Talk Reduces Vaccine Clinic Wait Time in Nigeria
Background: Wait time at vaccine clinics is a barrier to routine childhood vaccinations in low‐ and middle‐income countries (LMICs). Waiting for a critical mass of clients to accrue before conducting the vaccine health education talk prolongs clinic time.Methods: We implemented a workflow change, including a looped audiovisual vaccine education talk on a solar‐powered television. We compared clients' average clinic time using a before‐and‐after study, time‐motion design, and surveyed providers and clients on their perspectives on the workflow change.Results: In the post‐implementation phase, compared to the pre‐implementation phase, the average clinic time for all clients and the subgroup who presented before 9:00 AM was significantly reduced by 13 and 31 min, respectively (p = 0.006 and < 0.000). Providers and clients were positive about the workflow change.Conclusion: A looped audiovisual vaccine education talk significantly reduces client vaccine clinic wait time and is acceptable to providers. Research on the impact of workflow change with alternate vaccine health talk delivery mode on vaccine uptake and completion is required.
- Open Access
- 26 June 2025
- Published by Medip Academy in International Journal of Advances in Medicine
- Vol. 12 (4) , 350-355
Asymptomatic congenital malaria among neonates of mothers attending antenatal clinic in University of Medical Sciences Teaching Hospital, Akure
Background: Congenital malaria can be a serious cause of morbidity and mortality in the neonates if not detected. Clinical features of congenital malaria are non-specific and could be confused with other forms of infections in the newborn. The study sets out to document presence of asymptomatic congenital malaria among neonates of mothers attending antenatal clinic in University of Medical Sciences Teaching Hospital, Akure. Methods: Mother-baby pairs were recruited into the study from the maternity section of the hospital, blood samples were taken from maternal peripheral blood, placental maternal side, cord blood and peripheral blood of the newborn babies and analyzed for presence of malaria parasite by microscopy methods. Data analyses were done using Statistical Package for the Social Sciences (SPSS) version 24.0 Results: Eighty-six (79.6%) of the babies were positive for malaria parasites, 59 (54.6%) of them were male children and 49(45.4%) were female. Fifty mothers (58.1%) had peripheral or placental parasitaemia. Babies of mothers who used long lasting insecticide treated nets (LLIN) and intermittent preventive therapy IPT-SP were significantly less infected while babies of first- and second-time mothers were significantly more infected. Majority of the babies 77/86 (89.5%) however had low intensity parasitaemia. Conclusions: Congenital malaria is no more a rare disease especially in endemic regions, prevention of mother-to-child transmission should be aggressively pursued.
- 26 June 2025
- Published by Medip Academy in International Journal of Advances in Medicine
- Vol. 12 (4) , 350-355
Open AccessAsymptomatic congenital malaria among neonates of mothers attending antenatal clinic in University of Medical Sciences Teaching Hospital, Akure
Background: Congenital malaria can be a serious cause of morbidity and mortality in the neonates if not detected. Clinical features of congenital malaria are non-specific and could be confused with other forms of infections in the newborn. The study sets out to document presence of asymptomatic congenital malaria among neonates of mothers attending antenatal clinic in University of Medical Sciences Teaching Hospital, Akure. Methods: Mother-baby pairs were recruited into the study from the maternity section of the hospital, blood samples were taken from maternal peripheral blood, placental maternal side, cord blood and peripheral blood of the newborn babies and analyzed for presence of malaria parasite by microscopy methods. Data analyses were done using Statistical Package for the Social Sciences (SPSS) version 24.0 Results: Eighty-six (79.6%) of the babies were positive for malaria parasites, 59 (54.6%) of them were male children and 49(45.4%) were female. Fifty mothers (58.1%) had peripheral or placental parasitaemia. Babies of mothers who used long lasting insecticide treated nets (LLIN) and intermittent preventive therapy IPT-SP were significantly less infected while babies of first- and second-time mothers were significantly more infected. Majority of the babies 77/86 (89.5%) however had low intensity parasitaemia. Conclusions: Congenital malaria is no more a rare disease especially in endemic regions, prevention of mother-to-child transmission should be aggressively pursued.
- Open Access
- 26 May 2025
- Published by Medip Academy in International Journal of Contemporary Pediatrics
- Vol. 12 (6) , 870-877
Malaria parasitaemia among the neonates in Akure Ondo State, Nigeria
Background: Congenital malaria is thought to be a relatively rare condition in which malaria parasite is transmitted from the mother to the baby during pregnancy or at childbirth. This is so either because the babies were not routinely screened or due to difficulty in detecting the relatively scanty parasite in the newborn period. The study set out to document malaria parasitemia among the neonates in Akure, Ondo state. Methods: Febrile babies admitted into the special care baby unit of University of Medical Sciences Teaching Hospital and Mother and Child Hospital, Akure were tested for malaria parasite using microscopy method and confirmed by nested PCR. Data were analysed using excel and SPSS version 25.0 Results: Nineteen percent of the babies were preterm, 81% were full term and the overall prevalence of malaria among them was 74.7% while prevalence of congenital malaria was 92.9% and prevalence of neonatal malaria was 54.1%. Plasmodium falciparum was the most prevalent infecting species (98.3%), first born babies and male children were significantly more infected (p=0.001). Conclusion: Prevalence of malaria was very high in this study. Malaria infection in the neonates can be difficult to diagnose because the clinical features are nonspecific and parasitaemia often scanty. Screening for malaria parasite should therefore be done as part of routing tests for the neonates.
- 26 May 2025
- Published by Medip Academy in International Journal of Contemporary Pediatrics
- Vol. 12 (6) , 870-877
Open AccessMalaria parasitaemia among the neonates in Akure Ondo State, Nigeria
Background: Congenital malaria is thought to be a relatively rare condition in which malaria parasite is transmitted from the mother to the baby during pregnancy or at childbirth. This is so either because the babies were not routinely screened or due to difficulty in detecting the relatively scanty parasite in the newborn period. The study set out to document malaria parasitemia among the neonates in Akure, Ondo state. Methods: Febrile babies admitted into the special care baby unit of University of Medical Sciences Teaching Hospital and Mother and Child Hospital, Akure were tested for malaria parasite using microscopy method and confirmed by nested PCR. Data were analysed using excel and SPSS version 25.0 Results: Nineteen percent of the babies were preterm, 81% were full term and the overall prevalence of malaria among them was 74.7% while prevalence of congenital malaria was 92.9% and prevalence of neonatal malaria was 54.1%. Plasmodium falciparum was the most prevalent infecting species (98.3%), first born babies and male children were significantly more infected (p=0.001). Conclusion: Prevalence of malaria was very high in this study. Malaria infection in the neonates can be difficult to diagnose because the clinical features are nonspecific and parasitaemia often scanty. Screening for malaria parasite should therefore be done as part of routing tests for the neonates.
- Open Access
- 29 April 2025
- Published by Medip Academy in International Journal of Research in Medical Sciences
- Vol. 13 (5) , 1831-1838
Malaria parasitaemia among the under-12 children in Akure, Ondo State, Nigeria
Background: Malaria is a preventable and curable but life-threatening disease that is transmitted to humans by female Anophelis mosquitoes. It is mostly found in tropical countries. The study sets out to determine the malaria parasitaemia among children under the age of 12 years in Akure, Ondo State. Methods: The study was a prospective, cross sectional and hospital-based where blood specimen were collected from children aged 1 day old to 12 years. Microscopy method was used to detect the malaria parasite and confirmed by nested PCR method. The data obtained were subjected to statistical analysis using Microsoft excel and the statistical package for the social sciences (SPSS) version 20.0 Results: Overall prevalence of malaria was 64.2%. The neonates had the highest prevalence of 96.8%. P. falciparum was the most predominant species (99.4%), prevalence of malaria decreases with increasing birth order but prevalence was significantly higher among children in the first birth order and lower socio-economic class. There was no significant difference between parasite intensity among gender, p=0.585. Majority of children (94.2%) were well nourished. Conclusions: The study showed that prevalence of malaria is high in children under 12 in Ondo State. The neonates were worse hit, though with least parasite intensity. We suggest intensified and concerted effort in malaria prevention and control in the state.
- 29 April 2025
- Published by Medip Academy in International Journal of Research in Medical Sciences
- Vol. 13 (5) , 1831-1838
Open AccessMalaria parasitaemia among the under-12 children in Akure, Ondo State, Nigeria
Background: Malaria is a preventable and curable but life-threatening disease that is transmitted to humans by female Anophelis mosquitoes. It is mostly found in tropical countries. The study sets out to determine the malaria parasitaemia among children under the age of 12 years in Akure, Ondo State. Methods: The study was a prospective, cross sectional and hospital-based where blood specimen were collected from children aged 1 day old to 12 years. Microscopy method was used to detect the malaria parasite and confirmed by nested PCR method. The data obtained were subjected to statistical analysis using Microsoft excel and the statistical package for the social sciences (SPSS) version 20.0 Results: Overall prevalence of malaria was 64.2%. The neonates had the highest prevalence of 96.8%. P. falciparum was the most predominant species (99.4%), prevalence of malaria decreases with increasing birth order but prevalence was significantly higher among children in the first birth order and lower socio-economic class. There was no significant difference between parasite intensity among gender, p=0.585. Majority of children (94.2%) were well nourished. Conclusions: The study showed that prevalence of malaria is high in children under 12 in Ondo State. The neonates were worse hit, though with least parasite intensity. We suggest intensified and concerted effort in malaria prevention and control in the state.
- Open Access
- 28 February 2025
- Published by Medip Academy in International Journal of Research in Medical Sciences
- Vol. 13 (3) , 1019-1026
Prevalence and outcomes of neonatal anaemia in university of medical sciences teaching hospital, Akure
Background: Neonatal anaemia is a public health problem associated with short- and long-term morbidities. It can lead to death if not immediately treated or impairment in brain maturation and development, tissue hypoxia and stunted growth eventually. The aim and objectives of the study is to determine prevalence, associated factors and immediate outcomes of neonatal anaemia in the University of Medical Sciences Teaching Hospital (UNIMEDTH), Akure. Methods: This was a retrospective review of the medical records of all consecutive neonatal admissions in the neonatal intensive care unit (NICU) of the hospital over a nine-month period. At admission, peripheral blood sample was collected routinely within one hour of life for Packed Cell Volume at the side laboratory. Other relevant data were extracted from the case files and documented in the excel sheet which were exported unto the Statistical Package for Social Sciences (SPSS) version 25.0 for analysis. Results: Of the 145 babies studied, 30 were anaemic with one mortality; 132 (91.1%) of them were admitted within 24 hours of life, the commonest morbidity among them was prematurity, ABO incompatibility, neonatal sepsis and anaemia. Caesarean delivery, very low birth weight, longer duration on admission, prematurity and lower gestational age were significantly associated with neonatal anaemia while gender was not. Conclusions: The prevalence of anaemia among neonates in UNIMEDTH was 20.7%. The mortality was 3.3% and the only death occurred among babies with feto-placental transfusion.
- 28 February 2025
- Published by Medip Academy in International Journal of Research in Medical Sciences
- Vol. 13 (3) , 1019-1026
Open AccessPrevalence and outcomes of neonatal anaemia in university of medical sciences teaching hospital, Akure
Background: Neonatal anaemia is a public health problem associated with short- and long-term morbidities. It can lead to death if not immediately treated or impairment in brain maturation and development, tissue hypoxia and stunted growth eventually. The aim and objectives of the study is to determine prevalence, associated factors and immediate outcomes of neonatal anaemia in the University of Medical Sciences Teaching Hospital (UNIMEDTH), Akure. Methods: This was a retrospective review of the medical records of all consecutive neonatal admissions in the neonatal intensive care unit (NICU) of the hospital over a nine-month period. At admission, peripheral blood sample was collected routinely within one hour of life for Packed Cell Volume at the side laboratory. Other relevant data were extracted from the case files and documented in the excel sheet which were exported unto the Statistical Package for Social Sciences (SPSS) version 25.0 for analysis. Results: Of the 145 babies studied, 30 were anaemic with one mortality; 132 (91.1%) of them were admitted within 24 hours of life, the commonest morbidity among them was prematurity, ABO incompatibility, neonatal sepsis and anaemia. Caesarean delivery, very low birth weight, longer duration on admission, prematurity and lower gestational age were significantly associated with neonatal anaemia while gender was not. Conclusions: The prevalence of anaemia among neonates in UNIMEDTH was 20.7%. The mortality was 3.3% and the only death occurred among babies with feto-placental transfusion.
- Open Access
- 12 April 2024
- Published by Springer Nature in Trials
- Vol. 25 (1) , 1-15
The World Health Organization Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns (ACTION-III) Trial: study protocol for a multi-country, multi-centre, double-blind, three-arm, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at high probability of late preterm birth in hospitals in low- resource countries
Background: Preterm birth complications are the leading cause of newborn and under-5 mortality. Over 85% of all preterm births occur in the late preterm period, i.e. between 34 and < 37 weeks of gestation. Antenatal corticosteroids (ACS) prevent mortality and respiratory morbidity when administered to women at high risk of an early preterm birth, i.e. < 34 weeks’ gestation. However, the benefits and risks of ACS in the late preterm period are less clear; both guidelines and practices vary between settings. Emerging evidence suggests that the benefits of ACS may be achievable at lower doses than presently used. This trial aims to determine the efficacy and safety of two ACS regimens compared to placebo, when given to women with a high probability of late preterm birth, in hospitals in low-resource countries. Methods: WHO ACTION III trial is a parallel-group, three-arm, individually randomized, double-blind, placebo-controlled trial of two ACS regimens: dexamethasone phosphate 4 × 6 mg q12h or betamethasone phosphate 4 × 2 mg q 12 h. The trial is being conducted across seven sites in five countries—Bangladesh, India, Kenya, Nigeria, and Pakistan. Eligible women are those with a gestational age between 34 weeks 0 days and 36 weeks 5 days, who have a high probability of preterm birth between 12 h and 7 days (up to 36 weeks 6 days gestation). The primary outcome is a composite of stillbirth or neonatal death within 72 h of birth or use of newborn respiratory support within 72 h of birth or prior to discharge from hospital, whichever is earlier. Secondary outcomes include safety and health utilization measures for both women and newborns. The sample size is 13,500 women. Discussion: This trial will evaluate the benefits and possible harms of ACS when used in women likely to have a late preterm birth. It will also evaluate a lower-dose ACS regimen based on literature from pharmacokinetic studies. The results of this trial will provide robust critical evidence on the safe and appropriate use of ACS in the late preterm period internationally. Trial registration: ISRCTN11434567. Registered on 7 June 2021.
- 12 April 2024
- Published by Springer Nature in Trials
- Vol. 25 (1) , 1-15
Open AccessThe World Health Organization Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns (ACTION-III) Trial: study protocol for a multi-country, multi-centre, double-blind, three-arm, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at high probability of late preterm birth in hospitals in low- resource countries
Background: Preterm birth complications are the leading cause of newborn and under-5 mortality. Over 85% of all preterm births occur in the late preterm period, i.e. between 34 and < 37 weeks of gestation. Antenatal corticosteroids (ACS) prevent mortality and respiratory morbidity when administered to women at high risk of an early preterm birth, i.e. < 34 weeks’ gestation. However, the benefits and risks of ACS in the late preterm period are less clear; both guidelines and practices vary between settings. Emerging evidence suggests that the benefits of ACS may be achievable at lower doses than presently used. This trial aims to determine the efficacy and safety of two ACS regimens compared to placebo, when given to women with a high probability of late preterm birth, in hospitals in low-resource countries. Methods: WHO ACTION III trial is a parallel-group, three-arm, individually randomized, double-blind, placebo-controlled trial of two ACS regimens: dexamethasone phosphate 4 × 6 mg q12h or betamethasone phosphate 4 × 2 mg q 12 h. The trial is being conducted across seven sites in five countries—Bangladesh, India, Kenya, Nigeria, and Pakistan. Eligible women are those with a gestational age between 34 weeks 0 days and 36 weeks 5 days, who have a high probability of preterm birth between 12 h and 7 days (up to 36 weeks 6 days gestation). The primary outcome is a composite of stillbirth or neonatal death within 72 h of birth or use of newborn respiratory support within 72 h of birth or prior to discharge from hospital, whichever is earlier. Secondary outcomes include safety and health utilization measures for both women and newborns. The sample size is 13,500 women. Discussion: This trial will evaluate the benefits and possible harms of ACS when used in women likely to have a late preterm birth. It will also evaluate a lower-dose ACS regimen based on literature from pharmacokinetic studies. The results of this trial will provide robust critical evidence on the safe and appropriate use of ACS in the late preterm period internationally. Trial registration: ISRCTN11434567. Registered on 7 June 2021.
- Open Access
- 25 June 2023
- Published by Medical and Dental Consultants Association of Nigeria, OOUTH Chapter in Annals of Health Research
- Vol. 9 (2) , 98-107
Clinical Profile and Short-Term Outcome of Malaria in Febrile Under-Five Children in a Secondary Health Facility
Background: Malaria remains an essential tropical protozoal disease, affecting both young and old. It manifests in complicated and uncomplicated forms with more grave consequences among Under-five children. Objective: To describe malaria's clinical profile and short-term outcomes in Under-five children in a secondary health facility in southwest Nigeria. Methods: This was a hospital-based and cross-sectional study. Five hundred children under the age of five years who presented with fever at the health facility were recruited into the study. The clinical manifestations were documented, and blood samples were examined for malaria parasitaemia. Results: Forty-eight children (9.6%) of the study subjects were neonates, 195 (39%) were infants, and the remaining 257 (51.4%) were aged 12 months to 5 years. One hundred and two (39.1%) of the 261 children positive for malaria presented with uncomplicated malaria, while 159 (60.9%) of this population had various complications. The overall mortality from malaria was 5.0%. Conclusion: More than 60% of the infected children had complications of malaria, and mortality was mainly due to late presentation. Therefore, malaria preventive strategies should be part of ongoing health interventions.
- 25 June 2023
- Published by Medical and Dental Consultants Association of Nigeria, OOUTH Chapter in Annals of Health Research
- Vol. 9 (2) , 98-107
Open AccessClinical Profile and Short-Term Outcome of Malaria in Febrile Under-Five Children in a Secondary Health Facility
Background: Malaria remains an essential tropical protozoal disease, affecting both young and old. It manifests in complicated and uncomplicated forms with more grave consequences among Under-five children. Objective: To describe malaria's clinical profile and short-term outcomes in Under-five children in a secondary health facility in southwest Nigeria. Methods: This was a hospital-based and cross-sectional study. Five hundred children under the age of five years who presented with fever at the health facility were recruited into the study. The clinical manifestations were documented, and blood samples were examined for malaria parasitaemia. Results: Forty-eight children (9.6%) of the study subjects were neonates, 195 (39%) were infants, and the remaining 257 (51.4%) were aged 12 months to 5 years. One hundred and two (39.1%) of the 261 children positive for malaria presented with uncomplicated malaria, while 159 (60.9%) of this population had various complications. The overall mortality from malaria was 5.0%. Conclusion: More than 60% of the infected children had complications of malaria, and mortality was mainly due to late presentation. Therefore, malaria preventive strategies should be part of ongoing health interventions.
- Open Access
- 7 March 2023
- Published by PAGEPress Publications in Annals of Clinical and Biomedical Research
- Vol. 4 (1)
A nine-year facility-based review of the pattern and outcome of neonatal tetanus in Ondo State, Nigeria
Tetanus is an infection caused by the Clostridium tetani; a ubiquitous Gram-positive, motile, spore-forming, and toxin-producing anaerobe. It is the only vaccine-preventable infection that is not communicable and which is still causing regrettable morbidity and mortality in newborns in Nigeria. The objective of this study was to review the pattern of neonatal tetanus infection and to document its outcome in a secondary health care level in South-west Nigeria. This was a hospital-based prospective study. Questionnaires were also administered to collect information from the parents. Out of a total of 4,277 out-born babies, 23 had Neonatal Tetanus (NNT). The mean incubation period was 6.62±2.2 days; the period of onset was less than 24 hours in 9 (39.1%) of the babies and greater than 24 hours in 14 (60.9%) babies. Four babies (17.4%) died, 4 (17.4%) left against medical advice, and the mean age at death was 11.7±3.5 days. Other clinical records showed that 56.5% of mothers did not receive antenatal care or tetanus toxoid, 65.2% had non-hospital deliveries, cord care was sub-optimal in the majority of cases, and the case fatality ratio was 17.4%. The study reveals that NNT still contributes to morbidities and mortalities among Nigerian neonates. The incidence per year, though, waxes and wanes with no particular pattern; the disease still has the tendency to dip the neonatal indices.
- 7 March 2023
- Published by PAGEPress Publications in Annals of Clinical and Biomedical Research
- Vol. 4 (1)
Open AccessA nine-year facility-based review of the pattern and outcome of neonatal tetanus in Ondo State, Nigeria
Tetanus is an infection caused by the Clostridium tetani; a ubiquitous Gram-positive, motile, spore-forming, and toxin-producing anaerobe. It is the only vaccine-preventable infection that is not communicable and which is still causing regrettable morbidity and mortality in newborns in Nigeria. The objective of this study was to review the pattern of neonatal tetanus infection and to document its outcome in a secondary health care level in South-west Nigeria. This was a hospital-based prospective study. Questionnaires were also administered to collect information from the parents. Out of a total of 4,277 out-born babies, 23 had Neonatal Tetanus (NNT). The mean incubation period was 6.62±2.2 days; the period of onset was less than 24 hours in 9 (39.1%) of the babies and greater than 24 hours in 14 (60.9%) babies. Four babies (17.4%) died, 4 (17.4%) left against medical advice, and the mean age at death was 11.7±3.5 days. Other clinical records showed that 56.5% of mothers did not receive antenatal care or tetanus toxoid, 65.2% had non-hospital deliveries, cord care was sub-optimal in the majority of cases, and the case fatality ratio was 17.4%. The study reveals that NNT still contributes to morbidities and mortalities among Nigerian neonates. The incidence per year, though, waxes and wanes with no particular pattern; the disease still has the tendency to dip the neonatal indices.
- Top Cited PapersOpen Access
- 27 February 2023
- Published by Springer Nature in Nature Human Behaviour
- Vol. 7 (4) , 529-544
Changes in preterm birth and stillbirth during COVID-19 lockdowns in 26 countries
Preterm birth (PTB) is the leading cause of infant mortality worldwide. Changes in PTB rates, ranging from −90% to +30%, were reported in many countries following early COVID-19 pandemic response measures (‘lockdowns’). It is unclear whether this variation reflects real differences in lockdown impacts, or perhaps differences in stillbirth rates and/or study designs. Here we present interrupted time series and meta-analyses using harmonized data from 52 million births in 26 countries, 18 of which had representative population-based data, with overall PTB rates ranging from 6% to 12% and stillbirth ranging from 2.5 to 10.5 per 1,000 births. We show small reductions in PTB in the first (odds ratio 0.96, 95% confidence interval 0.95–0.98, P value <0.0001), second (0.96, 0.92–0.99, 0.03) and third (0.97, 0.94–1.00, 0.09) months of lockdown, but not in the fourth month of lockdown (0.99, 0.96–1.01, 0.34), although there were some between-country differences after the first month. For high-income countries in this study, we did not observe an association between lockdown and stillbirths in the second (1.00, 0.88–1.14, 0.98), third (0.99, 0.88–1.12, 0.89) and fourth (1.01, 0.87–1.18, 0.86) months of lockdown, although we have imprecise estimates due to stillbirths being a relatively rare event. We did, however, find evidence of increased risk of stillbirth in the first month of lockdown in high-income countries (1.14, 1.02–1.29, 0.02) and, in Brazil, we found evidence for an association between lockdown and stillbirth in the second (1.09, 1.03–1.15, 0.002), third (1.10, 1.03–1.17, 0.003) and fourth (1.12, 1.05–1.19, <0.001) months of lockdown. With an estimated 14.8 million PTB annually worldwide, the modest reductions observed during early pandemic lockdowns translate into large numbers of PTB averted globally and warrant further research into causal pathways.
- 27 February 2023
- Published by Springer Nature in Nature Human Behaviour
- Vol. 7 (4) , 529-544
Top Cited PapersOpen AccessChanges in preterm birth and stillbirth during COVID-19 lockdowns in 26 countries
Preterm birth (PTB) is the leading cause of infant mortality worldwide. Changes in PTB rates, ranging from −90% to +30%, were reported in many countries following early COVID-19 pandemic response measures (‘lockdowns’). It is unclear whether this variation reflects real differences in lockdown impacts, or perhaps differences in stillbirth rates and/or study designs. Here we present interrupted time series and meta-analyses using harmonized data from 52 million births in 26 countries, 18 of which had representative population-based data, with overall PTB rates ranging from 6% to 12% and stillbirth ranging from 2.5 to 10.5 per 1,000 births. We show small reductions in PTB in the first (odds ratio 0.96, 95% confidence interval 0.95–0.98, P value <0.0001), second (0.96, 0.92–0.99, 0.03) and third (0.97, 0.94–1.00, 0.09) months of lockdown, but not in the fourth month of lockdown (0.99, 0.96–1.01, 0.34), although there were some between-country differences after the first month. For high-income countries in this study, we did not observe an association between lockdown and stillbirths in the second (1.00, 0.88–1.14, 0.98), third (0.99, 0.88–1.12, 0.89) and fourth (1.01, 0.87–1.18, 0.86) months of lockdown, although we have imprecise estimates due to stillbirths being a relatively rare event. We did, however, find evidence of increased risk of stillbirth in the first month of lockdown in high-income countries (1.14, 1.02–1.29, 0.02) and, in Brazil, we found evidence for an association between lockdown and stillbirth in the second (1.09, 1.03–1.15, 0.002), third (1.10, 1.03–1.17, 0.003) and fourth (1.12, 1.05–1.19, <0.001) months of lockdown. With an estimated 14.8 million PTB annually worldwide, the modest reductions observed during early pandemic lockdowns translate into large numbers of PTB averted globally and warrant further research into causal pathways.
- 17 October 2022
- Published by Springer Nature in Journal of Parasitic Diseases
- Vol. 47 (1) , 59-67
Pfmdr 1 and kelch 13 genes distribution among children that are 5 years and below in Akure, Nigeria
Malaria parasite resistant to drugs has been a major barrier to effective treatment of malaria. Therefore, the study aimed to evaluate the distribution of Plasmodium falciparum resistant Kelch protein gene on chromosome 13 (Kelch 13) and multidrug resistant (Pfmdr1) mutant genes among children aged five years and below who attended Mother and Child Hospital, Akure, Nigeria. Thin and thick smears were prepared from the blood collected aseptically through venepuncture from five hundred (500) children. Structured questionnaires were used to obtain demographic data from the respondents. Two hundred malaria positive samples were randomly selected from the 500 samples for PCR analysis to detect Pfmdr1 and Kelch 13 mutant genes. The results showed that of the 500 respondents, 288 (57.6%) were males while 21 (42.4%) were females. Pfmdr1distribution include: mixed group (mutant/wild) 38.5%, mutant gene 35.5%, wild gene 20.5% and the resistant genes were absent in 5.5% of the infected children. The mixed group of Pfmdr1 gene was higher among infants (51.9%), children with birth order 4 (60.0%) and children that have blood group B (51.3%), however, there is no significant difference in the distribution of Pfmdr1 between gender (χ2 = 0.634, df = 1, p > 0.05). There was a point mutation in the codon position 557 where the amino acid Alanine was replaced by Serine in the PfK13. The presence of Pfmdr1 mutant genes and point mutation in the PfK13 gene of P. falciparum among children, calls for development of innovative drugs targeted on these resistant strains.
- 17 October 2022
- Published by Springer Nature in Journal of Parasitic Diseases
- Vol. 47 (1) , 59-67
Pfmdr 1 and kelch 13 genes distribution among children that are 5 years and below in Akure, Nigeria
Malaria parasite resistant to drugs has been a major barrier to effective treatment of malaria. Therefore, the study aimed to evaluate the distribution of Plasmodium falciparum resistant Kelch protein gene on chromosome 13 (Kelch 13) and multidrug resistant (Pfmdr1) mutant genes among children aged five years and below who attended Mother and Child Hospital, Akure, Nigeria. Thin and thick smears were prepared from the blood collected aseptically through venepuncture from five hundred (500) children. Structured questionnaires were used to obtain demographic data from the respondents. Two hundred malaria positive samples were randomly selected from the 500 samples for PCR analysis to detect Pfmdr1 and Kelch 13 mutant genes. The results showed that of the 500 respondents, 288 (57.6%) were males while 21 (42.4%) were females. Pfmdr1distribution include: mixed group (mutant/wild) 38.5%, mutant gene 35.5%, wild gene 20.5% and the resistant genes were absent in 5.5% of the infected children. The mixed group of Pfmdr1 gene was higher among infants (51.9%), children with birth order 4 (60.0%) and children that have blood group B (51.3%), however, there is no significant difference in the distribution of Pfmdr1 between gender (χ2 = 0.634, df = 1, p > 0.05). There was a point mutation in the codon position 557 where the amino acid Alanine was replaced by Serine in the PfK13. The presence of Pfmdr1 mutant genes and point mutation in the PfK13 gene of P. falciparum among children, calls for development of innovative drugs targeted on these resistant strains.